MENU
ANNX
AS OF
Nov 13, 04:59 PM (EDT)
Price
$2.69
Change
-$0.15 (-5.28%)
Capitalization
339.16M
116 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ANNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Annexon (ANNX) Earnings Date & Reports

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye... Show more

A.I. Advisor
published Earnings

ANNX is expected to report earnings to fall 10.81% to -33 cents per share on March 09

Annexon ANNX Stock Earnings Reports
Q4'25
Est.
$-0.33
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.07
Q4'24
Missed
by $0.06
The last earnings report on November 10 showed earnings per share of -37 cents, missing the estimate of -35 cents. With 1.81M shares outstanding, the current market capitalization sits at 339.16M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ANNX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANNX showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ANNX
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1400 Sierra Point Parkway
Phone
+1 650 822-5500
Employees
71
Web
https://www.annexonbio.com